The Niemann Pick C1 Like Protein 1 pipeline drugs market research report outlays comprehensive information on the Niemann Pick C1 Like Protein 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Niemann Pick C1 Like Protein 1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, and Hormonal Disorders which include the indications Hypercholesterolemia, Dyslipidemia, Hypertension, Atherosclerosis, and Endocrine Gland Disorders. It also reviews key players involved in Niemann Pick C1 Like Protein 1 targeted therapeutics development with respective active and dormant or discontinued products.
The Niemann Pick C1 Like Protein 1 pipeline targets constitutes close to ten molecules. Out of which, approximately ten molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, and Phase I stages are 6, 1, and 3 respectively.
Niemann Pick C1 Like Protein 1 overview
Niemann-Pick C1-like protein 1 (NPC1L1) is a protein involved in the regulation of cholesterol absorption in the intestine. It plays a key role in the process by which dietary cholesterol is taken up from the small intestine into enterocytes (intestinal cells) and then transported into the bloodstream. NPC1L1 is primarily expressed in the small intestine and the liver.
For a complete picture of Niemann Pick C1 Like Protein 1’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.